Literature DB >> 9710233

Expansion of IL-3-responsive IL-4-producing non-B non-T cells correlates with anemia and IL-3 production in mice infected with blood-stage Plasmodium chabaudi malaria.

H Helmby1, M Kullberg, M Troye-Blomberg.   

Abstract

A prominent switch of CD4+ T cells from Th1 to Th2 type response occurs in mice infected with the non-lethal malaria parasite Plasmodium chabaudi chabaudi AS around the time of peak parasitemia. This is reflected by a decrease in IFN-gamma- and an increase in IL-4-producing cells. The peak occurs approximately 9-10 days after infection and is accompanied by anemia. The mechanism behind the switch in Th cell response is poorly understood. We here report on the production of IL-4 from a non-T cell source during P. chabaudi infection in BALB/c mice. Flow cytometric analysis of spleen and peripheral blood leukocytes (PBL) showed a dramatic increase in the percentage of non-B non-T (NBNT) cells 9-23 days after P. chabaudi infection with peak values by day 15 (approximately 30 % of splenocytes and approximately 55 % of PBL being NBNT cells). The expansion of NBNT cells correlated closely with the appearance of a cell type secreting IL-4 and IL-6 following stimulation with IL-3 and/or cross-linking of FcgammaR. Compared to cells from uninfected animals, NBNT cells from P. chabaudi-infected mice were shown to be hyper-responsive to IL-3. The levels of the hematopoietic cytokine IL-3 were elevated in supernatants from unstimulated spleen cell cultures as well as in serum at the same time points at which NBNT cell-derived IL-4 and IL-6 were detected from spleen cultures and PBL. Thus, IL-3-responsive IL-4-producing NBNT cells may provide cytokines supporting the switch from Th1 to a Th2 response which is important for the final clearance of the parasite in P. chabaudi malaria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710233     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2559::AID-IMMU2559>3.0.CO;2-M

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

3.  Immunophenotyping of blood mononuclear cells from P. berghei (NK-65) infected and immunized BALB/c mice.

Authors:  Vineet Kumar; Aruna Rakha; Ruchika Saroa; Upma Bagai
Journal:  J Parasit Dis       Date:  2016-06-03

4.  Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS.

Authors:  H Helmby; G Jönsson; M Troye-Blomberg
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  A systematic review and meta-analysis of blood interleukin-4 levels concerning malaria infection and severity.

Authors:  Kwuntida Uthaisar Kotepui; Phiman Thirarattanasunthon; Pongruj Rattaprasert; Manas Kotepui
Journal:  Malar J       Date:  2022-07-12       Impact factor: 3.469

6.  Gastrointestinal nematode infection exacerbates malaria-induced liver pathology.

Authors:  Helena Helmby
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

7.  Cytokine dysregulation associated with malarial anemia in Plasmodium yoelii infected mice.

Authors:  Lili Xu; Xiaoying Zheng; Klavs Berzins; Asok Chaudhuri
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

8.  Interleukin-3-deficient mice have increased resistance to blood-stage malaria.

Authors:  Sarah R Auclair; Kenneth E Roth; Bryan L Saunders; Kathryn M Ogborn; Abdalla A Sheikh; Julianne Naples; Anna Marie P Young; Dorottya K Boisen; Amelia T Tavangar; Jane E Welch; Chris S Lantz
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.